Molecular mechanisms underlying anorexia nervosa: Focus on human gene association studies and systems controlling food intake

  title={Molecular mechanisms underlying anorexia nervosa: Focus on human gene association studies and systems controlling food intake},
  author={Mathias Rask-Andersen and Pawel K Olszewski and Allen S. Levine and Helgi Birgir Schi{\"o}th},
  journal={Brain Research Reviews},

Tables from this paper

The genetics of eating disorders.

Molecular studies have attempted to define genetic risk factors for these disorders, including case-control and family-based candidate gene association studies and linkage analysis of multiply affected nuclear families, and further GWAS results are expected in the near future.

Variability in cannabinoid receptor genes is associated with psychiatric comorbidities in anorexia nervosa

The association of genetic variants in cannabinoid receptors with the risk for Anorexia Nervosa and with psychiatric comorbidities that are commonplace in these patients was analyzed and significant CNR1/CNR2 epistasis was observed in relation to Hostility, Asceticism and Maturity Fears.

Epigenetic regulation of the cannabinoid receptor CB1 in an activity-based rat model of anorexia nervosa.

The transcriptional regulation of the endocannabinoid system, an interesting target for body weight maintenance and the control of food intake and energy balance, supports a possible role for Cnr1 in the ABA animal model of anorexia nervosa.

Dopamine in anorexia nervosa: a systematic review

Clinical studies on the etiology of AN have produced contradictory findings, and there are promising results with respect to the use of atypical antipsychotics against symptoms of AN beyond weight gain, but further trials are required.

The impact of COMT, BDNF and 5-HTT brain-genes on the development of anorexia nervosa: a systematic review

The systematic review distinctively emphasized the genetic contribution of the brain-genes on the development of AN and no clear and standardized genetic route was determined to be the cause of AN development.

Common genetic background in anorexia nervosa and obsessive compulsive disorder: preliminary results from an association study.

Underlying Susceptibility to Eating Disorders and Drug Abuse: Genetic and Pharmacological Aspects of Dopamine D4 Receptors

The dopamine D4 receptor (DRD4) has a predominant expression in the prefrontal cortex (PFC), brain area strictly involved in the modulation of reward processes related to both food and drug consumption, and the presence of the 7R variant seems to increase the susceptibility of individuals to engage maladaptive eating patterns in response to negative environmental stimuli.

BDNF genetic variability modulates psychopathological symptoms in patients with eating disorders

Preliminary results suggest that variability in the BDNF gene locus may contribute to anthropometric characteristics and also psychopathological symptoms that are common but not exclusive of ED patients.

Genetic risk factors for eating disorders: an update and insights into pathophysiology

Important findings derived from formal and molecular genetics are reviewed in order to outline a genetics-based pathophysiological model of eating disorders, which takes into account environmental and nutritional factors, genetic factors related to the microbiome, the metabolic and endocrine system, the immune system, and the brain, in addition to phenotypical traits of EDs.

Translational neuroscience of anorexia nervosa: A genetic and environmental interplay underlying behavioural hyperactivity in mice

The studies described in this thesis suggest that the trajectory of anorexia nervosa is likely defined by an ongoing gene and environment interplay starting at an early stage, and early life events may modulate genetic background susceptibility for adult maladaptive behavior via epigenetic modifications.



Association of BDNF with restricting anorexia nervosa and minimum body mass index: a family-based association study of eight European populations

Results support the involvement of BDNF in eating behaviour and further suggest its participation in the genetic susceptibility to ED, mainly ANR and low minBMI.

Lack of Association between Anorexia Nervosa and D3 Dopamine Receptor Gene

Association of BDNF with anorexia, bulimia and age of onset of weight loss in six European populations.

The Met66 variant is strongly associated to all ED subtypes, and the -270C BDNF variant has an effect on BN and late age at onset of weight loss, the first two variants associated with the pathophysiology of ED in different populations and support a role for BDNF in the susceptibility to aberrant eating behaviors.

Association of Multiple DRD2 Polymorphisms with Anorexia Nervosa

Genetically transmitted variation in D2 dopamine receptor expression mediated by functional polymorphisms affecting transcription and translation efficiency may play a role in vulnerability to AN.

Association study of cannabinoid receptor gene (CNR1) alleles and anorexia nervosa: Differences between restricting and bingeing/purging subtypes

  • Z. SiegfriedK. Kanyas E. M. Berry
  • Biology
    American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics
  • 2004
It is suggested that restricting AN and bingeing/purging AN may be associated with different alleles of the CNR1 gene, which encodes human CB1 receptor, a subclass of the central cannabinoid receptor.

Decreased levels of serum brain-derived neurotrophic factor in female patients with eating disorders

Single nucleotide polymorphisms in the leptin receptor gene: studies in anorexia nervosa

Leptin receptor SNPs do not appear to be important factors in the regulation of body weight in young, pre-menopausal women or have any significant association with anorexia nervosa.

Association of anorexia nervosa with the high activity allele of the COMT gene: a family-based study in Israeli patients

This study suggests that the COMT gene is associated with genetic susceptibility to AN, and that individuals homozygous for the high activity allele (HH) have a two-fold increased risk for development of the disorder.

Drug target discovery by pharmacogenetics: mutations in the melanocortin system and eating disorders